In 2023, total pharmaceutical sales in Belgium stood at 9.72 Billion US Dollars. Based on forecasted data, sales are expected to increase progressively from 2024 to 2028. In 2024, sales are projected to reach 9.93 Billion, representing a year-on-year increase of 2.16% from 2023. Further growth is expected with sales reaching 10.14 Billion in 2025 (a 2.11% increase), 10.35 Billion in 2026 (a 2.07% increase), 10.56 Billion in 2027 (a 2.03% increase), and finally 10.77 Billion in 2028 (a 1.99% increase). Over the five-year span from 2024 to 2028, the compound annual growth rate (CAGR) is approximately 2.07%.
Key future trends to watch for include the impact of new pharmaceutical innovations, regulatory changes, and potential shifts in healthcare policies. Monitoring these factors will be crucial for understanding the potential variations in the forecasted sales growth in the Belgian pharmaceutical market.
